ES2179839T3 - Macrocapsulas microporosas. - Google Patents

Macrocapsulas microporosas.

Info

Publication number
ES2179839T3
ES2179839T3 ES94902302T ES94902302T ES2179839T3 ES 2179839 T3 ES2179839 T3 ES 2179839T3 ES 94902302 T ES94902302 T ES 94902302T ES 94902302 T ES94902302 T ES 94902302T ES 2179839 T3 ES2179839 T3 ES 2179839T3
Authority
ES
Spain
Prior art keywords
macrocapsula
implementation
capsules
microporous
macrocapsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94902302T
Other languages
English (en)
Inventor
Frank T Gentile
Patrick A Tresco
Tyrone Hazlett
Thomas Flanagan
Edward J Doherty
David Rein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brown University Research Foundation Inc
Original Assignee
Brown University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brown University Research Foundation Inc filed Critical Brown University Research Foundation Inc
Application granted granted Critical
Publication of ES2179839T3 publication Critical patent/ES2179839T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LAS CAPSULAS MICROPOROSAS SE REVELAN COMO UTILES MECANISMOS DE IMPLANTACION EN LA TERAPIA CELULAR. LA MACROCAPSULA SE COMPONE DE CELULAS VIVAS QUE SECRETAN SUBSTANCIAS BIOLOGICAS CON VALOR TERAPEUTICO QUE SE LIBERAN DESDE LA MACROCAPSULA AL LUGAR DE IMPLANTACION. LAS CAPSULAS PUEDEN TENER UNAS CARACTERISTICAS DE PERMEABILIDAD SELECTIVAS DEPENDIENDO DE SU USO CONCRETO Y LAS CARACTERISTICAS DE COERCIVIDAD VIRICA DESEADAS.
ES94902302T 1992-11-16 1993-11-16 Macrocapsulas microporosas. Expired - Lifetime ES2179839T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97535492A 1992-11-16 1992-11-16

Publications (1)

Publication Number Publication Date
ES2179839T3 true ES2179839T3 (es) 2003-02-01

Family

ID=25522938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94902302T Expired - Lifetime ES2179839T3 (es) 1992-11-16 1993-11-16 Macrocapsulas microporosas.

Country Status (20)

Country Link
US (1) US6337088B1 (es)
EP (1) EP0674497B1 (es)
JP (1) JPH08503472A (es)
KR (1) KR950703910A (es)
AT (1) ATE220883T1 (es)
AU (1) AU687371B2 (es)
BR (1) BR9307455A (es)
CA (1) CA2149420C (es)
CZ (1) CZ122795A3 (es)
DE (1) DE69332149T2 (es)
DK (1) DK0674497T3 (es)
ES (1) ES2179839T3 (es)
FI (1) FI952322A7 (es)
HU (1) HUT72986A (es)
LV (1) LV10906B (es)
NZ (1) NZ258720A (es)
PL (1) PL309012A1 (es)
PT (1) PT674497E (es)
SK (1) SK62495A3 (es)
WO (1) WO1994010950A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965125A (en) 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
US6419920B1 (en) 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
CN103251449B (zh) 2005-10-13 2016-03-02 斯恩蒂斯有限公司 载药包装物
US20090196854A1 (en) * 2008-02-04 2009-08-06 Kytos Biosystems S.A. Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
CN105555328B (zh) 2013-06-21 2019-01-11 德普伊新特斯产品公司 膜及制造方法
RU2019131719A (ru) * 2017-04-06 2021-05-06 Сераксис, Инк. Макроинкапсулированные терапевтические клетки и способы их применения
CN112203667A (zh) 2018-03-01 2021-01-08 塞拉克西斯股份有限公司 大包封的治疗性细胞、装置及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4806355A (en) * 1983-06-06 1989-02-21 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4803168A (en) * 1983-09-01 1989-02-07 Damon Biotech, Inc. Microencapsulation with polymers
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US5015476A (en) * 1989-08-11 1991-05-14 Paravax, Inc. Immunization implant and method
CA2109085C (en) * 1991-04-25 2003-03-11 Keith E. Dionne Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products

Also Published As

Publication number Publication date
PL309012A1 (en) 1995-09-18
CA2149420C (en) 2007-04-17
SK62495A3 (en) 1995-11-08
CZ122795A3 (en) 1996-02-14
AU5671394A (en) 1994-06-08
CA2149420A1 (en) 1994-05-26
LV10906A (lv) 1995-12-20
FI952322L (fi) 1995-07-11
EP0674497B1 (en) 2002-07-24
HU9501426D0 (en) 1995-06-28
ATE220883T1 (de) 2002-08-15
KR950703910A (ko) 1995-11-17
DK0674497T3 (da) 2002-11-18
FI952322A0 (fi) 1995-05-12
FI952322A7 (fi) 1995-07-11
DE69332149T2 (de) 2003-02-27
NZ258720A (en) 1997-07-27
LV10906B (en) 1996-06-20
US6337088B1 (en) 2002-01-08
BR9307455A (pt) 1999-06-01
HUT72986A (en) 1996-06-28
EP0674497A1 (en) 1995-10-04
AU687371B2 (en) 1998-02-26
JPH08503472A (ja) 1996-04-16
DE69332149D1 (de) 2002-08-29
PT674497E (pt) 2002-12-31
WO1994010950A1 (en) 1994-05-26
EP0674497A4 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
FI961855L (fi) Hermostojärjestelmään kuuluvien kantasolujen manipulointi ja modifiointi
DK447886A (da) Mikrocellulaere sammensatte energirige materialer og fremgangsmaade til deres fremstilling
AU5849080A (en) Lightweight cements and their use in cementing bore holes
DE69431562D1 (de) Pharmazeutische formulierungen enthaltend nervenwachstumsfaktor
NO872228D0 (no) Farmakologisk aktive diaryl-3-substituert-pyrazoler og fremgangsmaate for deres fremstilling.
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
NO902027L (no) Poroese polymere strukturer og fremgangsmaate for deres fremstilling.
NO834866L (no) Cellelinjer og deres bruk for fremstilling av proteiner
DK138185A (da) Eventuelt poroese intumescensmasser og deres anvendelse
DK0848632T3 (da) Byggelegetøj primært til dannelse af rullebaner
DE3677115D1 (de) Zusammengesetzter ionenaustauscher und seine herstellung.
ES2179839T3 (es) Macrocapsulas microporosas.
DK230288A (da) Farmaceutiske praeparater i form af smaa perler og fremgangsmaade til deres fremstilling
IT1180204B (it) Dispersioni stabili di polimeri organici in poliepossidi e procedimento per preparare tali dispersioni
FI891718A7 (fi) Menetelmä ei-toivottujen kantojen soluseosten ja kudosten vapauttamise ksi
DK229189A (da) Modificerede blokpolymerisater, deres fremstilling og anvendelse
ATE102957T1 (de) Peptidstrukturen, sie enthaltende immunogene und deren anwendung zur kontrolle der fertilitaet.
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
FI901876A7 (fi) Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito
DK0650327T3 (da) Forbedringer i relation til kiks og deres fremstilling
Radford Culture, economy and urban structure in Charleston, South Carolina, 1860-1880.
EP0631617A4 (en) Puzzling cell mitogen in the colon, cell line that makes it and uses.
DK408285A (da) Gaerceller med foroeget permeabilitet, deres fremstilling og anvendelse
Bernas The innovation process of individualized instruction in some elementary schools in the Philippines: towards a model of an innovation process in educational organizations
Banerjee Representation and class politics in the theatre of Utpal Dutt